Nexalin Technology (NXL) Non-Current Debt (2021)
Nexalin Technology (NXL) posted quarterly Non-Current Debt of $22916.0 for Q4 2021.
Nexalin Technology (NXL) Non-Current Debt (2021) Analysis & Trends
Nexalin Technology's Non-Current Debt history runs 1 years deep, the most recent figure standing at $22916.0 for Q4 2021.
- In Q4 2021, Non-Current Debt changed N/A year-over-year to $22916.0; the TTM figure through Dec 2021 stood at $22916.0 (changed N/A YoY), while the FY2021 annual figure was $22916.0, changed N/A from the prior year.
- Non-Current Debt for Q4 2021 stood at $22916.0.
- The five-year high for Non-Current Debt was $22916.0 in Q4 2021, with the low at $22916.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Nexalin Technology | 7.00 Mn | 6.00 Mn | 8,897.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22,916.00 |